罗欣药业: 公司章程（2025年6月）

Group 1 - The company is named Luoxin Pharmaceuticals Group Co., Ltd and was established in accordance with the Company Law of the People's Republic of China [1] - The company was approved by the China Securities Regulatory Commission to issue 25 million shares of ordinary stock to the public on March 16, 2016, and was listed on the Shenzhen Stock Exchange on April 15, 2016 [1][3] - The registered capital of the company is RMB 1,087,588,486, with a total of 1,087,588,486 shares issued, all of which are ordinary shares [3][9] Group 2 - The company aims to maximize the interests of the company and its shareholders as its operational principle [4] - The business scope includes the production and wholesale of medical devices, pharmaceutical production, and related technical services [5] Group 3 - The company’s shares are issued in the form of stocks, with each share having a par value of RMB 1 [15] - The company’s shares are subject to equal rights for all shareholders, and the issuance of shares must adhere to principles of openness, fairness, and justice [15][16] Group 4 - The company has a total of 75 million ordinary shares at its establishment, with the total share capital fully subscribed by the founders [6][9] - The company’s founding shareholders include various individuals and entities, with specific contributions detailed [6][7][8]